4.7 Article

The Prevalence and Correlates of Binge Eating Disorder in the World Health Organization World Mental Health Surveys

Journal

BIOLOGICAL PSYCHIATRY
Volume 73, Issue 9, Pages 904-914

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.biopsych.2012.11.020

Keywords

Binge eating disorder; bulimia nervosa; comorbidity; epidemiology; treatment; WHO World Mental Health Surveys

Funding

  1. United States National Institute of Mental Health [R01MH070884]
  2. Mental Health Burden Study [HHSN271200700030C]
  3. John D. and Catherine T. MacArthur Foundation
  4. Pfizer Foundation
  5. US Public Health Service [R13-MH066849, R01-MH069864, R01 DA016558]
  6. Fogarty International Center [FIRCA R03-TW006481]
  7. Pan American Health Organization
  8. Eli Lilly & Company Foundation
  9. Ortho-McNeil Inc.
  10. GlaxoSmithKline
  11. Bristol-Myers Squibb
  12. Shire
  13. Ministry of Social Protection
  14. European Commission [QLG5-1999-01042, SANCO 2004123, EAHC 20081308]
  15. Piedmont Region (Italy)
  16. Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain [FIS 00/0028]
  17. Ministerio de Ciencia y Tecnologia, Spain [SAF 2000-158-CE]
  18. Departament de Salut, Generalitat de Catalunya, Spain, Instituto de Salud Carlos III [CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP]
  19. Ministry of Health
  20. Israel National Institute for Health Policy and Health Services Research
  21. National Insurance Institute of Israel
  22. Japan Ministry of Health, Labour and Welfare [H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013]
  23. Lebanese Ministry of Public Health
  24. WHO (Lebanon)
  25. Fogarty International
  26. Act for Lebanon
  27. Janssen Cilag
  28. Eli Lilly
  29. Roche
  30. Novartis
  31. National Institute of Psychiatry Ramon de la Fuente [INPRFMDIES 4280]
  32. National Council on Science and Technology [CONACyT-G30544-H]
  33. PanAmerican Health Organization
  34. WHO (Geneva)
  35. WHO (Nigeria)
  36. Federal Ministry of Health, Abuja, Nigeria
  37. US National Institute of Mental Health [RO1-MH61905]
  38. National Institute of Mental Health [U01-MH60220]
  39. National Institute of Drug Abuse
  40. Substance Abuse and Mental Health Services Administration
  41. Robert Wood Johnson Foundation [044708]
  42. John W. Alden Trust

Ask authors/readers for more resources

Background: Little population-based data exist outside the United States on the epidemiology of binge eating disorder (BED). Cross-national BED data are presented here and compared with bulimia nervosa (BN) data in the World Health Organization (WHO) World Mental Health Surveys. Methods: Community surveys with 24,124 respondents (ages 18+) across 14 mostly upper-middle and high-income countries assessed lifetime and 12-month DSM-IV mental disorders with the WHO Composite International Diagnostic Interview. Physical disorders were assessed with a chronic conditions checklist. Results: Country-specific lifetime prevalence estimates are consistently (median; interquartile range) higher for BED (1.4%;.8-1.9%) than BN (.8%; .4-1.0%). Median age of onset is in the late teens to early 20s for both disorders but slightly younger for BN. Persistence is slightly higher for BN (6.5 years; 2.2-15.4) than BED (4.3 years; 1.0-11.7). Lifetime risk of both disorders is elevated for women and recent cohorts. Retrospective reports suggest that comorbid DSM-IV disorders predict subsequent onset of BN somewhat more strongly than BED and that BN predicts subsequent comorbid disorders somewhat more strongly than does BED. Significant comorbidities with physical conditions are due almost entirely to BN and to a somewhat lesser degree BED predicting subsequent onset of these conditions. Role impairments are similar for BN and BED. Fewer than half of lifetime BN or BED cases receive treatment. Conclusions: Binge eating disorder represents a public health problem at least equal to BN. Low treatment rates highlight the clinical importance of questioning patients about eating problems even when not included among presenting complaints.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available